HER2-positive Breast Cancer Registry

The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

HER2 + Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

KUCC - Indian Creek, Overland Park, Kansas, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Stage I-IV HER2-positive breast cancer

Exclusion criteria

None

Treatment and study plan

Primary outcomes

Overall survival rate

Time frame: From diagnosis to 5 years after diagnosis

For patients with stage I-III HER2-positive breast cancer, percentage of patients who are alive at 5 years after diagnosis.

Secondary outcomes

Pathologic complete response rate

Time frame: From start of neoadjuvant systemic treatment until approximately 8 months after start of neoadjuvant systemic treatment

Percentage of patients with stage I-III HER2-positive breast cancer who received neoadjuvant systemic therapy and experienced pathologic complete response.

Study contacts

Contact information is provided by the study sponsor or research team.

Study Coordinator

CONTACT

[email protected]

913-588-6079

Sponsors and collaborators

Lead sponsor

Priyanka Sharma

Other

Registry information

Official study title

Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)

Acronym: PRO-HER2

Important dates

Study start: 2024
Primary completion: 2044
Study completion: 2044
First posted: Sep 19, 2024
Registry last updated: Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting